Raymond Wadlow, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Pfizer
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    10/28/2026
    Relationship end date:
    11/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Incyte
    Topic:
    Anal Cancer
    Date added:
    12/27/2025
    Date updated:
    10/28/2026
    Relationship end date:
    10/22/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    BeOne
    Topic:
    Gastrointestinal Cancers
    Date added:
    12/27/2025
    Date updated:
    10/28/2026
    Relationship end date:
    11/25/2027
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Ipsen
    Topic:
    Pancreatic cancer
    Date added:
    10/28/2026
    Date updated:
    10/28/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Exact Sciences
    Topic:
    Colorectal cancer
    Date added:
    10/28/2026
    Date updated:
    10/28/2026
    Relationship end date:
    07/01/2027
Return to 2026 Inova GI Oncology Multi-Disciplinary Care Planning Meeting 11/16/2026